IP Library Granted Patent US 9,345,733
Granted Patent B1
US 9,345,733 · App. 13/573,406 · Granted May 24, 2016

Supplement composition for supporting telomere maintenance and protection and method of use

Inventors: Vincent C. Giampapa (Montclair, NJ); David B. Cross (Chappaqua, NY)
Assignee: CELLHEALTH TECHNOLOGIES LTD.
A61K36/28A61K31/05A61K31/197A61K31/198A61K31/7048A61K36/16A61K36/258
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,345,733
App. No.
13/573,406
Granted
May 24, 2016
Kind
B1
Abstract

A supplement composition for supporting telomere maintenance and protection, including effective amounts of extract of silybum marianum ; N-acetylcysteine; Resveratrol; Extract of Panax ginseng ; Extract of Ginkgo biloba ; Puerarin; and L-arginine. Further disclosed is a method for supporting telomere maintenance and protection, comprising orally administering a supplement composition to a person one or twice daily, said supplement composition comprising in one dosage: from about 100 mg to about 300 mg of extract of silybum marianum , from about 400 mg to about 600 mg of N-acetylcysteine, from about 40 mg to about 60 mg of trans-resveratrol, from about 80 mg to about 120 mg of extract of Panax ginseng , from about 40 mg to about 60 mg of extract of ginkgo biloba , and from about 80 mg to about 120 mg of puerarin, and from about 400 mg to about 600 mg of L-arginine.

Claims (4)

1. A method for increasing telomerase activity comprising orally administering a supplement composition to a person one or twice daily, said supplement composition comprising in one dosage: 200 mg of extract of silybum marianum standardized to 80% silymarin, 500 mg of N-acetylcysteine, 50 mg of trans-resveratrol from Polygonum cuspidatum, 100 mg of extract of Panax ginseng, 50 mg of extract of ginkgo biloba, 100 mg of puerarin derived from Radix puerariae, and 500 mg of L-arginine, magnesium sterate, silica, and pharmaceutical glaze.

2. The method of claim 1 comprising administering the composition in an morning dose and evening dose.

3. The method of claim 1 comprising administering a second supplement composition wherein the second supplement composition comprises a multivitamin.

4. The method of claim 3 comprising administering the second supplement composition in a morning and evening dose.

Assignments (4)
SECURITY INTEREST Recorded Jan 8, 2026
From: LIFE SCIENCE INSTITUTE, LLC
To: TRAILBLAZE HOLDINGS LLC
Reel/Frame 073412/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2018
From: CELLHEALTH TECHNOLOGIES, LLC
To: LIFE SCIENCE INSTITUTE, LLC
Reel/Frame 047291/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2014
From: GIAMPAPA, VINCENT, M.D.
To: LIFE SCIENCE INSTITUTE, LLC.
Reel/Frame 032337/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2014
From: LIFE SCIENCE INSTITUTE, LLC.
To: CELLHEALTH TECHNOLOGIES LTD.
Reel/Frame 032337/0806 →
Continuity (1)
Provisional Application 61534708 · Sep 14, 2011